5-Year Follow-Up of CALGB 40502 Study in TNBC

December 13, 2017
Hope S. Rugo, MD

Hope S. Rugo, MD, professor of medicine and director of the Breast Oncology Clinical Trials Program at the UCSF Helen Diller Family Comprehensive Cancer Center, discusses the 5-year follow-up of the CALGB 40502 study for patients with triple-negative breast cancer (TNBC).